Ky. attorney defies brain cancer odds through Markey clinical trial

Ky. attorney defies brain cancer odds through Markey clinical trial

LEXINGTON, Ky. (May 15, 2025) — As a University of Kentucky alum, David Higdon has strong connections…

Continue Reading
EyePoint to Share DURAVYU Clinical Trial Updates at TD Cowen Healthcare Conference

EyePoint to Share DURAVYU Clinical Trial Updates at TD Cowen Healthcare Conference

EyePoint Pharmaceuticals (NASDAQ: EYPT) announced that its President and CEO, Jay S. Duker,…

Continue Reading
Clinical signs and symptoms for degenerative cervical myelopathy: a scoping review of case-control studies to facilitate early diagnosis among healthcare professionals with stakeholder engagement

Clinical signs and symptoms for degenerative cervical myelopathy: a scoping review of case-control studies to facilitate early diagnosis among healthcare professionals with stakeholder engagement

Nouri A, Tessitore E, Molliqaj G, Meling T, Schaller K, Nakashima H, et al. Degenerative cervical…

Continue Reading
AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

Powerful combination delivers immediate, dilation-free, fully autonomous AI diagnostic screening with 100% imageability for referable diabetic…

Continue Reading
Clinical Guidance for Pediatric Mild TBI | Traumatic Brain Injury & Concussion

Clinical Guidance for Pediatric Mild TBI | Traumatic Brain Injury & Concussion

Continue Reading
Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference

Sling Therapeutics to Announce Topline Results from Phase 2b/3 LIDS Clinical Trial of Oral Small Molecule Linsitinib in Patients with Thyroid Eye Disease at the 43rd Annual J.P. Morgan Healthcare Conference

ANN ARBOR, Mich., Jan. 13, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a late-stage biopharmaceutical company focused…

Continue Reading